206 related articles for article (PubMed ID: 16998648)
1. CSF protein profiling using Multiplex Immuno-assay: A potential new diagnostic tool for leptomeningeal metastases.
Brandsma D; Voest EE; de Jager W; Bonfrer H; Algra A; Boogerd W; Korse T; Reijneveld JC; Verbeek MM; Rijkers G; Taphoorn MJ
J Neurol; 2006 Sep; 253(9):1177-84. PubMed ID: 16998648
[TBL] [Abstract][Full Text] [Related]
2. EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.
Milojkovic Kerklaan B; Pluim D; Bol M; Hofland I; Westerga J; van Tinteren H; Beijnen JH; Boogerd W; Schellens JH; Brandsma D
Neuro Oncol; 2016 Jun; 18(6):855-62. PubMed ID: 26566655
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors.
Lin X; Fleisher M; Rosenblum M; Lin O; Boire A; Briggs S; Bensman Y; Hurtado B; Shagabayeva L; DeAngelis LM; Panageas KS; Omuro A; Pentsova EI
Neuro Oncol; 2017 Sep; 19(9):1248-1254. PubMed ID: 28821205
[TBL] [Abstract][Full Text] [Related]
4. CSF levels of growth factors and plasminogen activators in leptomeningeal metastases.
van de Langerijt B; Gijtenbeek JM; de Reus HP; Sweep FC; Geurts-Moespot A; Hendriks JC; Kappelle AC; Verbeek MM
Neurology; 2006 Jul; 67(1):114-9. PubMed ID: 16832089
[TBL] [Abstract][Full Text] [Related]
5. SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis).
Vinayanuwattikun C; Mingmalairak S; Jittapiromsak N; Thaipisuttikul I; Sriuranpong V; Mutirangura A; Shuangshoti S
J Neurooncol; 2016 Sep; 129(3):395-403. PubMed ID: 27401153
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis.
Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z
Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis.
Straathof CS; de Bruin HG; Dippel DW; Vecht CJ
J Neurol; 1999 Sep; 246(9):810-4. PubMed ID: 10525979
[TBL] [Abstract][Full Text] [Related]
8. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
[TBL] [Abstract][Full Text] [Related]
9. A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases.
Chamberlain MC; Kormanik PA; Glantz MJ
Neuro Oncol; 2001 Jan; 3(1):42-5. PubMed ID: 11305416
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier
Integrity in Lung Cancer Patients with Leptomeningeal Metastasis].
Lin Y; Yu T; Li H; Yin Z; Guo A
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):567-576. PubMed ID: 34120432
[TBL] [Abstract][Full Text] [Related]
11. Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases.
Ying S; Ke H; Ding Y; Liu Y; Tang X; Yang D; Li M; Liu J; Yu B; Xiang J; Mao X; Han-Zhang H; Hu W; Chen L
Cancer Biol Ther; 2019; 20(4):562-570. PubMed ID: 30395779
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value.
Herrlinger U; Wiendl H; Renninger M; Förschler H; Dichgans J; Weller M
Br J Cancer; 2004 Jul; 91(2):219-24. PubMed ID: 15213721
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 CSF levels predict survival in patients with leptomeningeal metastases.
Brandsma D; Taphoorn MJ; de Jager W; Bonfrer H; Algra A; Reijneveld JC; Boogerd W; Korse T; Verbeek MM; Rijkers GT; Voest EE
Neurology; 2006 Jan; 66(2):243-6. PubMed ID: 16434663
[TBL] [Abstract][Full Text] [Related]
14. Glucosephosphate isomerase as a CSF marker for leptomeningeal metastasis.
Newton HB; Fleisher M; Schwartz MK; Malkin MG
Neurology; 1991 Mar; 41(3):395-8. PubMed ID: 2006007
[TBL] [Abstract][Full Text] [Related]
15. Imaging features of leptomeningeal metastases.
Collie DA; Brush JP; Lammie GA; Grant R; Kunkler I; Leonard R; Gregor A; Sellar RJ
Clin Radiol; 1999 Nov; 54(11):765-71. PubMed ID: 10580769
[TBL] [Abstract][Full Text] [Related]
16. Therapy of leptomeningeal metastasis in solid tumors.
Mack F; Baumert BG; Schäfer N; Hattingen E; Scheffler B; Herrlinger U; Glas M
Cancer Treat Rev; 2016 Feb; 43():83-91. PubMed ID: 26827696
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.
Galicia N; Díez P; Dégano RM; Guest PC; Ibarrola N; Fuentes M
Adv Exp Med Biol; 2017; 974():85-96. PubMed ID: 28353226
[TBL] [Abstract][Full Text] [Related]
18. [Spinal metastases combined with leptomeningeal metastasis: A case report].
Ma LJ; Hu PP; Liu XG
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):563-566. PubMed ID: 37291936
[TBL] [Abstract][Full Text] [Related]
19. CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases.
Reijneveld JC; Brandsma D; Boogerd W; Bonfrer JG; Kalmijn S; Voest EE; Geurts-Moespot A; Visser MC; Taphoorn MJ
Neurology; 2005 Oct; 65(7):1120-2. PubMed ID: 16217072
[TBL] [Abstract][Full Text] [Related]
20. CSF CA 15-3 in breast cancer-related leptomeningeal metastases.
Le Rhun E; Kramar A; Salingue S; Girot M; Rodrigues I; Mailliez A; Zairi F; Bakhache E; Robin YM; Taillibert S; Dubois F; Bonneterre J; Chamberlain MC
J Neurooncol; 2014 Mar; 117(1):117-24. PubMed ID: 24469852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
